Azelis to buy S&D’s pharma ingredients biz
Belgian chemicals distributor Azelis has agreed to buy S&D Group citing its presence in key pharmaceutical ingredients markets as an important driver.
Belgian chemicals distributor Azelis has agreed to buy S&D Group citing its presence in key pharmaceutical ingredients markets as an important driver.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, DPT, PharmaNet and CTI.
A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.
Update
Lab Research's main Canadian lender has obtained an order appointing receivers under section 243 of the bankruptcy and insolvency act after the firm's US private equity suitor lost interest in a takeover.
GlaxoSmithKline (GSK) has confirmed that job cuts in its neurosciences group will affect less than 50 people, but half those cuts are coming from the company's US headquarters in North Carolina.
A shortage of investigators with knowledge of trial regulations and ethics is an obstacle to growth of Indian clinical research.
AstraZeneca has become the latest drug firm to invest in Russian manufacturing capcity with the announcment of plans for a $150m facility in the country’s Kaluga region.